News and Trends 11 Apr 2023
Calida Therapeutics launches to tackle thrombo-inflammatory disorders
Calida Therapeutics, a preclinical stage biotech company specializing in thrombo-inflammatory disorders, has announced its incorporation in Paris, France. Calida Therapeutics has already raised €2 million ($2.17 million) in seed funding…